Stockholders’ Equity - Schedule of Total Warrants Outstanding (Details)	3 Months Ended
Mar. 31, 2026 $ / shares shares
Schedule of Total Warrants Outstanding [Line Items]
Outstanding, Beginning	1,044,167
Exercised
Outstanding, Ending	1,044,167
Placement agent warrants [Member]
Schedule of Total Warrants Outstanding [Line Items]
Issue Date	July - Sept 2022
Exercise Price Per Share (in Dollars per share) \| $ / shares	$ 45
Expiration Date	July - Sept 2027
Outstanding, Beginning	767
New Issuance
Exercised
Outstanding, Ending	767
Placement agent warrants [Member]
Schedule of Total Warrants Outstanding [Line Items]
Issue Date	Nov 2022
Exercise Price Per Share (in Dollars per share) \| $ / shares	$ 15
Expiration Date	Nov 2027
Outstanding, Beginning	1,000
New Issuance
Exercised
Outstanding, Ending	1,000
Representative Warrants [Member]
Schedule of Total Warrants Outstanding [Line Items]
Issue Date	Jan 2023
Exercise Price Per Share (in Dollars per share) \| $ / shares	$ 90
Expiration Date	Jan 2028
Outstanding, Beginning	5,600
New Issuance
Exercised
Outstanding, Ending	5,600
Placement agent warrants [Member]
Schedule of Total Warrants Outstanding [Line Items]
Issue Date	July 2023
Exercise Price Per Share (in Dollars per share) \| $ / shares	$ 32.81
Expiration Date	Jan 2029
Outstanding, Beginning	18,572
New Issuance
Exercised
Outstanding, Ending	18,572
New Series A-1 warrants [Member]
Schedule of Total Warrants Outstanding [Line Items]
Issue Date	Nov 2024
Exercise Price Per Share (in Dollars per share) \| $ / shares	$ 16.5
Expiration Date	Nov 2029
Outstanding, Beginning	285,715
New Issuance
Exercised
Outstanding, Ending	285,715
New Series A-2 warrants [Member]
Schedule of Total Warrants Outstanding [Line Items]
Issue Date	Nov 2024
Exercise Price Per Share (in Dollars per share) \| $ / shares	$ 16.5
Expiration Date	May 2026
Outstanding, Beginning	285,715
New Issuance
Exercised
Outstanding, Ending	285,715
Placement agent warrants [Member]
Schedule of Total Warrants Outstanding [Line Items]
Issue Date	Nov 2024
Exercise Price Per Share (in Dollars per share) \| $ / shares	$ 20.625
Expiration Date	Nov 2029
Outstanding, Beginning	18,571
New Issuance
Exercised
Outstanding, Ending	18,571
Investor Warrants 2025 [Member]
Schedule of Total Warrants Outstanding [Line Items]
Issue Date	Dec 2025
Exercise Price Per Share (in Dollars per share) \| $ / shares	$ 10.6
Expiration Date	Dec 2027
Outstanding, Beginning	414,748
Exercised
Outstanding, Ending	414,748
Placement agent warrants [Member]
Schedule of Total Warrants Outstanding [Line Items]
Issue Date	Dec 2025
Exercise Price Per Share (in Dollars per share) \| $ / shares	$ 13.5625
Expiration Date	Dec 2027
Outstanding, Beginning	13,479
Exercised
Outstanding, Ending	13,479

Expiration Date.

No definition available.

Name:	cvkd_ClassOfWarrantOrRightExpirationDate
Namespace Prefix:	cvkd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	instant

- Definition

Issue Date.

+ References

No definition available.

+ Details

Name:	cvkd_ClassOfWarrantOrRightIssueDate
Namespace Prefix:	cvkd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.

+ References

No definition available.

+ Details

Name:	cvkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised
Namespace Prefix:	cvkd_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(4))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_FinancialInstrumentAxis=cvkd_PlacementAgentWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=cvkd_PlacementAgentWarrantOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=cvkd_RepresentativeWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=cvkd_PlacementAgentWarrantsTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=cvkd_NewSeriesA1WarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=cvkd_NewSeriesA2WarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=cvkd_PlacementAgentWarrantsThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=cvkd_InvestorWarrants2025Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FinancialInstrumentAxis=cvkd_PlacementAgentWarrantsFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: